Patent · US Active

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

US11896572B2 · kind B2 · utility

23Cited by

263References

1Claims

0Family size

Assignee

Flamel Ireland Limited · IE

Inventors

Jordan Dubow · Chicago, US
Hervé Guillard · Villeurbanne, FR
Claire Mégret · L'Essart Mador, FR
Jean-François Dubuisson · L'Essart Mador, FR

Key dates

Filing date	Aug 8, 2023
Grant date	Feb 13, 2024
Priority date	—
Expiry date	Aug 8, 2043

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/5047
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.